Your browser doesn't support javascript.
loading
Total Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma Is Associated With Limited Lymph Node Yield but Improved Ratio.
Barrak, Dany; Villano, Anthony M; Moslim, Maitham A; Hopkins, Steven E; Lefton, Max D; Ruth, Karen; Reddy, Sanjay S.
Affiliation
  • Barrak D; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Villano AM; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Moslim MA; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Hopkins SE; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Lefton MD; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Ruth K; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Reddy SS; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Electronic address: sanjay.reddy@fccc.edu.
J Surg Res ; 280: 543-550, 2022 12.
Article in En | MEDLINE | ID: mdl-36096019

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Surg Res Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Surg Res Year: 2022 Document type: Article Country of publication: United States